Earlier evidence from Mendelian randomization and large cohort studies suggested an association between Lp(a) and atherosclerotic cardiovascular disease (ASCVD), underscoring its significance in the pathophysiology of cardiovascular diseases (CVD) and sparking increased interest in this lipoprotein (3, 4). This evidence concerns the gene LPA and atherosclerosis.